We are live on
!
Find out more
TC
Tavio Capital Portfolio holdings
AUM
$75.4M
1-Year Est. Return
27.99%
This Fund
S&P 500
This Quarter
Est. Return
+2.94%
1 Year Est. Return
+27.99%
3 Year Est. Return
+81.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$212M
AUM Growth
+$28.8M
(+16%)
Cap. Flow
+$31.2M
Cap. Flow
% of AUM
14.72%
Top 10 Holdings %
Top 10 Hldgs %
92.32%
Holding
13
New
5
Increased
3
Reduced
3
Closed
1
Top Buys
| 1 |
Humana
HUM
|
+$17.7M |
| 2 |
Cardinal Health
CAH
|
+$16.6M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$14.2M |
| 4 |
HCA Healthcare
HCA
|
+$12.6M |
| 5 |
Elevance Health
ELV
|
+$10.2M |
Top Sells
| 1 |
Cencora
COR
|
+$35.3M |
| 2 |
Universal Health Services
UHS
|
+$14.8M |
| 3 |
Boston Scientific
BSX
|
+$2.13M |
| 4 |
Molina Healthcare
MOH
|
+$199K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Elevance Health
ELV
$80.9B
| $39.1M | 18.42% |
177,813
+43,259
| +32% | +$10.2M |
|
|
2
Molina Healthcare
MOH
$11.7B
| $26.6M | 12.57% |
328,272
-2,475
| -0.7% | -$199K |
|
3
CVS Health
CVS
$137B
| $24.6M | 11.59% |
395,240
+57,703
| +17% | +$4.14M |
|
|
4
Boston Scientific
BSX
$65.4B
| $19.5M | 9.22% |
715,494
-78,371
| -10% | -$2.13M |
|
|
5
Humana
HUM
$48B
| $17.6M | 8.3% |
+65,497
| New | +$17.7M |
|
|
6
Cardinal Health
CAH
$53.5B
| $15.1M | 7.14% |
+241,546
| New | +$16.6M |
|
7
DaVita
DVA
$15.2B
| $14.1M | 6.65% |
213,772
+4,642
| +2% | +$341K |
|
|
8
Universal Health Services
UHS
$9.15B
| $13.3M | 6.25% |
111,967
-125,012
| -53% | -$14.8M |
|
|
ALXN
9
DELISTED
Alexion Pharmaceuticals
ALXN
| $13.2M | 6.24% |
+118,689
| New | +$14.2M |
|
|
10
HCA Healthcare
HCA
$82.3B
| $12.6M | 5.94% |
+129,933
| New | +$12.6M |
|
11
Heron Therapeutics
HRTX
$89.1M
| $9.71M | 4.58% |
+351,729
| New | +$7.98M |
|
12
Travere Therapeutics
TVTX
$5.27B
| $6.57M | 3.1% |
293,923
| – | – |
|
|
13
Cencora
COR
$59.9B
| – | – |
-384,697
| Closed | -$35.3M |
|
Similar funds
PC
EGPO
AIS
MCMT
NBG
FC
SCM
MVM
Tavio Capital's Q1 2018 Portfolio in Review
As of Q1 2018, Tavio Capital held 13 positions worth $212M, up 16% from $183M the previous quarter. Its ten largest holdings account for 92% of the portfolio.
Tavio Capital deployed $31.2M of net new capital in Q1 2018, opening 5 new positions and adding to 3 existing holdings. Its largest new stake was Humana: 65,497 shares worth $17.6M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
On the sell side, the largest reduction was Universal Health Services, an estimated $14.8M trimmed.
- Tavio Capital's largest Q1 2018 buy was Humana: 65,497 shares worth $17.6M.
- Tavio Capital added most to Elevance Health in Q1 2018, an estimated $10.2M increase.
- Tavio Capital's biggest Q1 2018 reduction was Universal Health Services, cutting an estimated $14.8M.
- Tavio Capital fully exited Cencora in Q1 2018, selling an estimated $35.3M.
- Tavio Capital's ten largest holdings make up 92% of its $212M portfolio in Q1 2018.
- Tavio Capital opened 5 new positions and closed 1 in Q1 2018.
- Tavio Capital's portfolio value rose 16% quarter-over-quarter to $212M.
Based on Tavio Capital's 13F filing for Q1 2018, filed 14 May 2018.